Zhejiang Orient Gene Biotech Co.,Ltd 688298.SS Stock
Zhejiang Orient Gene Biotech Co.,Ltd Price Chart
Zhejiang Orient Gene Biotech Co.,Ltd 688298.SS Financial and Trading Overview
Zhejiang Orient Gene Biotech Co.,Ltd stock price | 28.73 CNY |
Previous Close | 49.98 CNY |
Open | 50.28 CNY |
Bid | 50.77 CNY x N/A |
Ask | 50.79 CNY x N/A |
Day's Range | 50.1 - 51.2 CNY |
52 Week Range | 48.91 - 138.88 CNY |
Volume | 1.24M CNY |
Avg. Volume | 1.77M CNY |
Market Cap | 8.53B CNY |
Beta (5Y Monthly) | 1.944995 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -8.26 CNY |
Forward Dividend & Yield | 6.18 (12.49%) |
Ex-Dividend Date | June 16, 2022 |
1y Target Est | N/A |
688298.SS Valuation Measures
Enterprise Value | 1.86B CNY |
Trailing P/E | N/A |
Forward P/E | 1.8923249 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.9402435 |
Price/Book (mrq) | 1.0535377 |
Enterprise Value/Revenue | 0.424 |
Enterprise Value/EBITDA | -8.273 |
Trading Information
Zhejiang Orient Gene Biotech Co.,Ltd Stock Price History
Beta (5Y Monthly) | 1.944995 |
52-Week Change | -62.36% |
S&P500 52-Week Change | 20.43% |
52 Week High | 138.88 CNY |
52 Week Low | 48.91 CNY |
50-Day Moving Average | 57.75 CNY |
200-Day Moving Average | 78.1 CNY |
688298.SS Share Statistics
Avg. Volume (3 month) | 1.77M CNY |
Avg. Daily Volume (10-Days) | 1.46M CNY |
Shares Outstanding | 168M |
Float | 25.72M |
Short Ratio | N/A |
% Held by Insiders | 49.95% |
% Held by Institutions | 10.34% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2 |
Trailing Annual Dividend Yield | 4.00% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 1.4:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -1.12% |
Operating Margin (ttm) | -7.15% |
Gross Margin | 16.28% |
EBITDA Margin | -5.12% |
Management Effectiveness
Return on Assets (ttm) | -1.76% |
Return on Equity (ttm) | -0.55% |
Income Statement
Revenue (ttm) | 4.4B CNY |
Revenue Per Share (ttm) | 26.19 CNY |
Quarterly Revenue Growth (yoy) | -92.10% |
Gross Profit (ttm) | 3.61B CNY |
EBITDA | -225168864 CNY |
Net Income Avi to Common (ttm) | -49295504 CNY |
Diluted EPS (ttm) | -5.12 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 7.24B CNY |
Total Cash Per Share (mrq) | 43.11 CNY |
Total Debt (mrq) | 625.14M CNY |
Total Debt/Equity (mrq) | 7.56 CNY |
Current Ratio (mrq) | 4.526 |
Book Value Per Share (mrq) | 48.209 |
Cash Flow Statement
Operating Cash Flow (ttm) | 490.24M CNY |
Levered Free Cash Flow (ttm) | -419041632 CNY |
Profile of Zhejiang Orient Gene Biotech Co.,Ltd
Country | China |
State | N/A |
City | Huzhou |
Address | No. 3787, East Yangguang Avenue |
ZIP | 313300 |
Phone | 86 57 2530 3755 |
Website | https://www.orientgene.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 2830 |
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products worldwide. The company offers IFA solutions, digital test, oral fluid test, and covid-19 test products; and immunological diagnosis product, such as hair drug test kit, monkeypox, saliva drug test, urine multi-drug test, urine single-drug test, rapid test, digital pregnancy test, male-fertility test, menopause test, and other test products. It also provides molecular diagnosis products, including nucleic acid extraction systems, real time PCR systems, virus detection kits, viral nucleic acid extraction kits, and general products; liquid biochip products; mini immunofluorescence analyzers, handheld fluorescence immunoassay analyzers, fluorescence immunoassay analyzers, handheld oral fluid drug test readers, colloidal gold test readers, and urine drug test cup readers; and dry biochemical strips comprising urine reagent strips, urine analyzers, alcohol test, and vaginal pH test products. In addition, the company offers raw materials for fertility, tumor and cardiac marker, drugs of abuse, infectious diseases, pet, antibody, and others; and FISH probes comprising solid tumor probes, chromosome test, hematologic disease probes, reagents, and instruments. Zhejiang Orient Gene Biotech Co., Ltd. was founded in 2005 and is based in Huzhou, China.
Q&A For Zhejiang Orient Gene Biotech Co.,Ltd Stock
What is a current 688298.SS stock price?
Zhejiang Orient Gene Biotech Co.,Ltd 688298.SS stock price today per share is 28.73 CNY.
How to purchase Zhejiang Orient Gene Biotech Co.,Ltd stock?
You can buy 688298.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zhejiang Orient Gene Biotech Co.,Ltd?
The stock symbol or ticker of Zhejiang Orient Gene Biotech Co.,Ltd is 688298.SS.
Which industry does the Zhejiang Orient Gene Biotech Co.,Ltd company belong to?
The Zhejiang Orient Gene Biotech Co.,Ltd industry is Medical Devices.
How many shares does Zhejiang Orient Gene Biotech Co.,Ltd have in circulation?
The max supply of Zhejiang Orient Gene Biotech Co.,Ltd shares is 201.6M.
What is Zhejiang Orient Gene Biotech Co.,Ltd Price to Earnings Ratio (PE Ratio)?
Zhejiang Orient Gene Biotech Co.,Ltd PE Ratio is now.
What was Zhejiang Orient Gene Biotech Co.,Ltd earnings per share over the trailing 12 months (TTM)?
Zhejiang Orient Gene Biotech Co.,Ltd EPS is -8.26 CNY over the trailing 12 months.
Which sector does the Zhejiang Orient Gene Biotech Co.,Ltd company belong to?
The Zhejiang Orient Gene Biotech Co.,Ltd sector is Healthcare.